AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded ...

AbbVie Inc.'s ( NYSE:ABBV ) dividend will be increasing from last year's payment of the same period to $1.73 on 17th ...

AbbVie remains a Strong Buy due to robust growth in immunology and neuroscience portfolios, offsetting Humira's decline.

AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Piper Sandler 37th Annual Healthcare Conference December 3, 2025 8:30 AM ESTCompany ParticipantsDavid Amsellem - MD & Senior ...

In the current session, the stock is trading at $233.57, after a 0.52% spike. Over the past month, AbbVie Inc. (NYSE:ABBV) stock increased by 0.94%, and in the past year, by 40.22%. With performance ...

Shares of AbbVie Inc. ABBV slid 2.87% to $229.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.55% to 6,705.12 and the ...

Shares of AbbVie Inc. ABBV shed 1.49% to $229.45 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.56% to 6,538.76 and Dow ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

North Chicago, Illinois-based AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. With a market cap of $405.6 billion, the company discovers and develops ...

Shares of Vertex Pharmaceuticals Inc. rose 6.92% to $463.13 Wednesday, on what proved to be an all-around positive trading ...